The latest news:

• Top Brain Tumor News Stories for 2016         2016 was an exciting year - but I think 2017 will be the year we see big steps forward! Happy New Year! BTW: The copay program will open again very soon - maybe Monday or Tuesday. Will announce it as soon as it opens!  
  



• Prognostic parameters and outcome after re-irradiation for progressive glioblastoma.         This suggests that stereotactc radiosurgery may be worth consdering for recurrent gbm. This is another controversial issue in the field.  Some doctors I talk with never use it, and others use it a lot.  This is why it is so important to get second opinions.
  



• A Rational Approach to Target the Epidermal Growth Factor Receptor in Glioblastomas.         We (the Musella Foundation) are partially funding this work!  Good luck to them.
  



• Absence of cytomegalovirus in glioblastoma and other high-grade gliomas by real-time PCR, immunohistochemistry and in situ hybridization.         This study shows that CMV is NOT associated with GBMs. Other studies show 100% of GBMs have it.  It is very important to get the 2 sides together and work out why one group finds it and the other group doesn't. Perhaps have both labs test the same samples, and also have them compare methodology.
  



• Florescent light helps surgeons target brain tumors         This is approved and a standard treatment in Europe. It is not yet approved in the USA so it is only available in clinical trials. Hopefully the new administration will relax some FDA rules and allow potentially life saving treatments to be approved sooner rather than later.
  



• Pathway linked to slower aging also fuels brain cancer         They need to find a way to target only the tumor cells and not have the side effects on the normal cells.  There is a lot of research going on to accomplish this with other treatments, such as antibody drug conjugates, convection enhanced delivery, super selective intraarterial intracranial infusion, gene therapies such as used by Tocagen and a few others.
  

BrainTumor Co-Payment Assistance Program Status:

• CLOSED to new applicants